ArticleNeuro-oncology2014

Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial.

Orin Bloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.